These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28414327)

  • 1. A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
    Sarkar S; Popov VL; O'Connell MR; Stevenson HL; Lee BS; Obeid RA; Luthra GK; Singh P
    Lab Invest; 2017 Oct; 97(10):1245-1261. PubMed ID: 28414327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
    Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P
    Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
    O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P
    Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer.
    Kalantari E; Ghods R; Saeednejad Zanjani L; Rahimi M; Eini L; Razmi M; Asadi-Lari M; Madjd Z
    Cancer Biomark; 2022; 33(3):277-289. PubMed ID: 34958000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles.
    Lazer LM; Kesavan Y; Gor R; Ramachandran I; Pathak S; Narayan S; Anbalagan M; Ramalingam S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112612. PubMed ID: 35738074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
    Moore LL; Houchen CW
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
    Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
    Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA.
    Kantara C; O'Connell M; Sarkar S; Moya S; Ullrich R; Singh P
    Cancer Res; 2014 May; 74(9):2487-98. PubMed ID: 24626093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.
    Vedeld HM; Skotheim RI; Lothe RA; Lind GE
    Epigenetics; 2014 Mar; 9(3):346-50. PubMed ID: 24384857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doublecortin-like kinase 1-positive enterocyte - a new cell type in human intestine.
    Leppänen J; Helminen O; Huhta H; Kauppila JH; Miinalainen I; Ronkainen VP; Saarnio J; Lehenkari PP; Karttunen TJ
    APMIS; 2016 Nov; 124(11):958-965. PubMed ID: 27677532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.
    Takiyama A; Tanaka T; Kazama S; Nagata H; Kawai K; Hata K; Otani K; Nishikawa T; Sasaki K; Kaneko M; Emoto S; Murono K; Takiyama H; Nozawa H
    In Vivo; 2018; 32(2):365-371. PubMed ID: 29475922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
    Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
    Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
    [No Abstract]   [Full Text] [Related]  

  • 17. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma.
    Reineking W; Schauerte IE; Junginger J; Hewicker-Trautwein M
    Vet Pathol; 2022 May; 59(3):415-426. PubMed ID: 35220825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of human
    Singh P; O'Connell M; Shubhashish S
    Stem Cell Investig; 2016; 3():51. PubMed ID: 27777940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.